The Thermo Scientific MAS Omni•CARDIO controls consolidate routine cardiac markers including Troponin I and T, CK-MB, Myoglobin, NT-proBNP and BNP-32 with several new cardiac/STAT markers including Myeloperoxidase, hCG, D-Dimer and Procalcitonin. These new analytes extend the usage of MAS Omni•CARDIO controls into the ER/ICU hospital setting, where rapid turnaround and reporting of tests is critical to the support of potentially life threatening situations.

The kits are on display in booth 5140 during the Clinical Lab Expo at the American Association for Clinical Chemistry (AACC) conference, being held at the George R. Brown Convention Center in Houston from July 30 - August 1.

MAS Omni•CARDIO offers five control levels—the available Ultra Low and Low options offer specific Troponin I and T low-level challenges, which are increasingly demanded by clinical laboratories.

Synonymous with quality, reliability, convenience and choice, the Thermo Scientific MAS Omni•CARDIO control products are the fourth addition to the MAS Omni quality control family, which also includes control kits marketed as MAS Omni•IMMUNE, MAS Omni•IMMUNE PRO and MAS Omni•CORE. In keeping with these other QC kits, the new MAS Omni•CARDIO control provides real-world benefits and cost savings through reduced QC usage.

Value assignment is provided for integrated instrument systems from the leading IVD manufacturers. QC results can also be submitted into Thermo Fisher’s web-based quality assurance program, LabLink xL, for daily and peer-based comparison.

The MAS Omni product line offers clinicians the opportunity to consolidate up to seven separate QC products into three while maintaining class-leading stability and performance claims.

For more information about Thermo Scientific MAS Omni quality controls, please call (510) 979-5000, email sales.diagnostics.fmt@thermofisher.com or visit www.thermoscientific.com/QC.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $13 billion, we have 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Visit www.thermofisher.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130730005437/en/

Contact: